Home > Journals > Minerva Ginecologica > Past Issues > Minerva Ginecologica 2015 April;67(2) > Minerva Ginecologica 2015 April;67(2):121-5

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints
Cite this article as

MINERVA GINECOLOGICA

A Journal on Obstetrics and Gynecology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index


eTOC

 

ORIGINAL ARTICLES  


Minerva Ginecologica 2015 April;67(2):121-5

Copyright © 2015 EDIZIONI MINERVA MEDICA

language: English

Hyaluronic acid-chondroitin sulfate: a potential factor to select pure stress urinary incontinence in patients with interstitial cystitis⁄painful bladder syndrome and mixed incontinence symptoms

Morelli M. 1, 2, Mocciaro R. 1, Venturella R. 1, Albano A. 1, Sacchinelli A. 1, Zullo F. 1, 2

1 Department of Obstetrics and Gynecology, “Magna Graecia” University, Catanzaro, Italy; 2 Unit of Gynecologic Oncology, “Tommaso Campanella” Cancer Center of Germaneto, Catanzaro, Italy


PDF  


AIM: Aim of the study was to validate the Hyaluronic acid–Chondroitin sulfate (HA-CS) as ex adiuvantibus criteria to identified patients with urgency symptoms related to interstitial cystitis/painful bladder syndrome (IC/PBS) and to obtained a population of patients with pure stress urinary incontinence.
METHODS: We retrospectively analysed clinical data of 17 patients with clinical suspect of IC/PBS, which received intravescical HA-CS to reduce pelvic pain and urgency symptoms waiting for surgical treatment for stress urinary incontinence. The main outcomes were reduction of urinary frequency, urgency, and bladder pain.
RESULTS: Compared to baseline, a significant decrease in pain, urgency and frequency were observed. Of the 17 patients, 82.3% reported resolution of pain and urge symptoms and in patients with persistence of urge symptoms the urodynamic assessment showed an overactive bladder syndrome (OAB).
CONCLUSION: HA-CS treatment induces an improvement in pain and urgency symptoms in patients with IC⁄PBS that referred also stress urinary incontinence. Therefore, HA-CS treatment could be use as clinical adjunctive parameter to select patients with pure stress urinary incontinence.

top of page

Publication History

Cite this article as

Morelli M, Mocciaro R, Venturella R, Albano A, Sacchinelli A, Zullo F. Hyaluronic acid-chondroitin sulfate: a potential factor to select pure stress urinary incontinence in patients with interstitial cystitis⁄painful bladder syndrome and mixed incontinence symptoms. Minerva Ginecol 2015 April;67(2):121-5. 

Corresponding author e-mail

rita.mocciaro@hotmail.it